Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (181-190 of 267) with videos related to

Pageof 27
Sort By:
BMC Medical Research Methodology|May 27, 2023
Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studiesMaeregu Woldeyes Arisido, Luisa Foco, Robin Shoemaker, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2019
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variabilityVirginie Siguret, Johan Abdoul, Xavier Delavenne, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2020
Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO StudyPhilippe Gosse, Antoine Cremer, Ajay J Kirtane, et al.
Scientific Reports|December 8, 2023
Circadian rhythm and circulating cell-free DNA release on healthy subjectsGeoffroy Poulet, Jean-Sébastien Hulot, Anne Blanchard, et al.
The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.
Journal of Hypertension|August 26, 2021
Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trialNaomi D L Fisher, Ajay J Kirtane, Joost Daemen, et al.
Hypertension (Dallas, Tex. : 1979)|August 30, 2021
Beyond Atherosclerosis and Fibromuscular Dysplasia: Rare Causes of Renovascular HypertensionAlexandre Persu, Caitriona Canning, Aleksander Prejbisz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2021
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trialFelix Mahfoud, Michael J Bloch, Michel Azizi, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
Pageof 27

Showing results (181-190 of 267) with videos related to

Sort By:
Pageof 27
BMC Medical Research Methodology|May 27, 2023
Cluster analysis of angiotensin biomarkers to identify antihypertensive drug treatment in population studiesMaeregu Woldeyes Arisido, Luisa Foco, Robin Shoemaker, et al.
Journal of Thrombosis and Haemostasis : JTH|June 20, 2019
Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variabilityVirginie Siguret, Johan Abdoul, Xavier Delavenne, et al.
Hypertension (Dallas, Tex. : 1979)|December 28, 2020
Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO StudyPhilippe Gosse, Antoine Cremer, Ajay J Kirtane, et al.
Scientific Reports|December 8, 2023
Circadian rhythm and circulating cell-free DNA release on healthy subjectsGeoffroy Poulet, Jean-Sébastien Hulot, Anne Blanchard, et al.
The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.
Journal of Hypertension|August 26, 2021
Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trialNaomi D L Fisher, Ajay J Kirtane, Joost Daemen, et al.
Hypertension (Dallas, Tex. : 1979)|August 30, 2021
Beyond Atherosclerosis and Fibromuscular Dysplasia: Rare Causes of Renovascular HypertensionAlexandre Persu, Caitriona Canning, Aleksander Prejbisz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2021
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trialFelix Mahfoud, Michael J Bloch, Michel Azizi, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Cancer Immunology, Immunotherapy : CII|November 12, 2010
A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findingsStéphane Oudard, Olivier Rixe, Benoit Beuselinck, et al.
Pageof 27